Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Br J Haematol. 2013 Aug 27;163(3):326–333. doi: 10.1111/bjh.12534

Figure 3. Median overall survival (OS) from diagnosis of CLL for patients who ultimately acquire “double hit” is poor (7.1 years).

Figure 3

Patients who ultimately acquire both 17p and 11q deletions (“double hit”) have a poor prognosis from time of diagnosis of CLL with a median OS of 7.1 years. When median survival for these patients is considered from the time-point of sentinel FISH event (when 17p- and 11q- are acquired), their prognosis is very poor (median OS 1.9 years). See Figure 2.